Patient Guide: An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 20 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06668181
Status: 🟢 Enrolling Now
Condition: Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis
Phase: PHASE3

Where You Can Participate

This study is available at 20 locations across the country.

Top locations include:
  • • Calgary,
  • • Saskatoon,
  • • Indre-et-Loire,
  • • And 17 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis - Join Clinical Trial NCTNCT06668181

How to Join This Clinical Trial - NCTNCT06668181

Learn how to participate in this PHASE3 trial studying an investigational therapy for Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06668181 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 20 locations. Find a study site near you:

Clinical Research Site

Calgary, - Canada

Status: RECRUITING

Clinical Research Site

Saskatoon, - Canada

Status: RECRUITING

Clinical Research Site

Indre-et-Loire, - France

Status: RECRUITING

Clinical Research Site

Le Kremlin-Bicêtre, - France

Status: RECRUITING

Clinical Research Site

Paris, - France

Status: RECRUITING

Clinical Research Site

Poitiers, - France

Status: RECRUITING

Clinical Research Site

Berlin, - Germany

Status: RECRUITING

Clinical Research Site

Freiburg im Breisgau, - Germany

Status: RECRUITING

Clinical Research Site

Sankt Augustin, - Germany

Status: RECRUITING

Clinical Research Site

Sendenhorst, - Germany

Status: RECRUITING

And 10 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships